Merus announces appointment of Jason Avery as Chief Business Officer
Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced that Jason Avery has been appointed as Chief Business Officer.
With a professional background as Head of Business Development at Affitech A/S and Chief Business Officer at Cambridge Antibody Technology, Jason Avery brings extensive industry experience to Merus.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.